mSEPT9 performs better than CEA in NAT response and MRD assessment and recurrence prediction of stage III CRC
mSEPT9 exhibits better applicability than CEA in assessment in terms of patient coverage, sensitivity and the pre-NAT recurrence prediction.
Authors
- Wenchuan Zhu
- Yun Shang (ORCID: https://orcid.org/0000-0002-2796-1309)
- Yunjun Zeng
- Jianxun Wang (ORCID: https://orcid.org/0000-0002-9030-1733)
- Jianlin Song
- Li Zhang (ORCID: https://orcid.org/0000-0002-3617-2627)
- Jianbiao Xu (ORCID: https://orcid.org/0000-0003-4769-8664)
- Tong‐Min Wang
- Xiaochun Yang (ORCID: https://orcid.org/0000-0002-3263-6789)
Institutions
- Kunming University of Science and Technology (CN)
- First People's Hospital of Yunnan Province (CN)
Publication Details
- Journal
- Biomarkers in Medicine
- Published
- 2025-04-08
- DOI
- https://doi.org/10.1080/17520363.2025.2489919
- Citations
- 2
- Primary Topic
- Radiomics and Machine Learning in Medical Imaging
- Type
- article
- Field-Weighted Citation Impact
- 2.72